Thermo Fisher Scientific Inc (TMO)
580.05
-4.10
(-0.70%)
USD |
NYSE |
Mar 18, 16:00
579.02
-1.03
(-0.18%)
Pre-Market: 06:00
Thermo Fisher Scientific Cash from Operations (TTM): 8.406B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.406B |
September 30, 2023 | 8.17B |
June 30, 2023 | 7.693B |
March 31, 2023 | 7.681B |
December 31, 2022 | 9.154B |
September 30, 2022 | 8.124B |
June 30, 2022 | 8.837B |
March 31, 2022 | 9.536B |
December 31, 2021 | 9.312B |
September 30, 2021 | 10.19B |
June 30, 2021 | 10.25B |
March 31, 2021 | 9.911B |
December 31, 2020 | 8.289B |
September 30, 2020 | 6.863B |
June 30, 2020 | 5.272B |
March 31, 2020 | 4.68B |
December 31, 2019 | 4.973B |
September 30, 2019 | 4.861B |
June 30, 2019 | 4.964B |
March 31, 2019 | 5.114B |
December 31, 2018 | 4.543B |
September 30, 2018 | 4.608B |
June 30, 2018 | 4.317B |
March 31, 2018 | 3.722B |
December 31, 2017 | 4.005B |
Date | Value |
---|---|
September 30, 2017 | 3.344B |
June 30, 2017 | 3.220B |
March 31, 2017 | 3.284B |
December 31, 2016 | 3.258B |
September 30, 2016 | 3.406B |
June 30, 2016 | 3.345B |
March 31, 2016 | 3.197B |
December 31, 2015 | 2.942B |
September 30, 2015 | 2.542B |
June 30, 2015 | 2.475B |
March 31, 2015 | 2.598B |
December 31, 2014 | 2.620B |
September 30, 2014 | 2.394B |
June 30, 2014 | 2.224B |
March 31, 2014 | 1.814B |
December 31, 2013 | 2.011B |
September 30, 2013 | 1.942B |
June 30, 2013 | 1.917B |
March 31, 2013 | 1.946B |
December 31, 2012 | 2.040B |
September 30, 2012 | 2.016B |
June 30, 2012 | 1.897B |
March 31, 2012 | 1.744B |
December 31, 2011 | 1.691B |
September 30, 2011 | 1.492B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
4.68B
Minimum
Mar 2020
10.25B
Maximum
Jun 2021
7.614B
Average
8.147B
Median
Cash from Operations (TTM) Benchmarks
Fonar Corp | 15.29M |
XWELL Inc | -19.66M |
ProPhase Labs Inc | -10.32M |
Applied DNA Sciences Inc | -7.592M |
OncoCyte Corp | -28.41M |